These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 38487137)
21. Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease. Sang Z; Pan W; Wang K; Ma Q; Yu L; Yang Y; Bai P; Leng C; Xu Q; Li X; Tan Z; Liu W Eur J Med Chem; 2017 Apr; 130():379-392. PubMed ID: 28279845 [TBL] [Abstract][Full Text] [Related]
22. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation. Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471 [TBL] [Abstract][Full Text] [Related]
23. Development of the "hidden" multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease. Chen R; Li X; Chen H; Wang K; Xue T; Mi J; Ban Y; Zhu G; Zhou Y; Dong W; Tang L; Sang Z Eur J Med Chem; 2023 May; 251():115253. PubMed ID: 36921526 [TBL] [Abstract][Full Text] [Related]
24. Association between acetylcholinesterase and beta-amyloid peptide in Alzheimer's cerebrospinal fluid. García-Ayllón MS; Silveyra MX; Sáez-Valero J Chem Biol Interact; 2008 Sep; 175(1-3):209-15. PubMed ID: 18554581 [TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase. Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339 [TBL] [Abstract][Full Text] [Related]
26. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease. Han J; Du Z; Lim MH Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227 [TBL] [Abstract][Full Text] [Related]
27. Jean L; Brimijoin S; Vaux DJ J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102 [TBL] [Abstract][Full Text] [Related]
28. In vitro acetylcholinesterase inhibitory activity and the antioxidant properties of Aegle marmelos leaf extract: implications for the treatment of Alzheimer's disease. Asaduzzaman M; Uddin MJ; Kader MA; Alam AH; Rahman AA; Rashid M; Kato K; Tanaka T; Takeda M; Sadik G Psychogeriatrics; 2014 Mar; 14(1):1-10. PubMed ID: 24646308 [TBL] [Abstract][Full Text] [Related]
29. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease. Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628 [TBL] [Abstract][Full Text] [Related]
30. Effects of BIS-MEP on Reversing Amyloid Plaque Deposition and Spatial Learning and Memory Impairments in a Mouse Model of β-Amyloid Peptide- and Ibotenic Acid-Induced Alzheimer's Disease. Wang Y; Xia J; Shen M; Zhou Y; Wu Z; Shi Y; Xu J; Hou L; Zhang R; Qiu Z; Xie Q; Chen H; Zhang Y; Wang H Front Aging Neurosci; 2019; 11():3. PubMed ID: 30723404 [TBL] [Abstract][Full Text] [Related]
31. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease. Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279 [TBL] [Abstract][Full Text] [Related]
32. The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer's disease. Fronza MG; Alves D; Praticò D; Savegnago L Ageing Res Rev; 2023 Sep; 90():102033. PubMed ID: 37595640 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic potential of ferulic acid and its derivatives in Alzheimer's disease-A systematic review. Phadke AV; Tayade AA; Khambete MP Chem Biol Drug Des; 2021 Nov; 98(5):713-721. PubMed ID: 34240555 [TBL] [Abstract][Full Text] [Related]
34. Indole-3 Carbinol and Diindolylmethane Mitigated β-Amyloid-Induced Neurotoxicity and Acetylcholinesterase Enzyme Activity: In Silico, In Vitro, and Network Pharmacology Study. Ramakrishna K; Karuturi P; Siakabinga Q; T A G; Krishnamurthy S; Singh S; Kumari S; Kumar GS; Sobhia ME; Rai SN Diseases; 2024 Aug; 12(8):. PubMed ID: 39195183 [No Abstract] [Full Text] [Related]
35. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation. Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578 [TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior. Sharma S; Verma S; Kapoor M; Saini A; Nehru B Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920 [TBL] [Abstract][Full Text] [Related]
37. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR). Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802 [TBL] [Abstract][Full Text] [Related]
38. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities. Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer's disease. Singh YP; Tej GNVC; Pandey A; Priya K; Pandey P; Shankar G; Nayak PK; Rai G; Chittiboyina AG; Doerksen RJ; Vishwakarma S; Modi G Eur J Med Chem; 2020 Jul; 198():112257. PubMed ID: 32375073 [TBL] [Abstract][Full Text] [Related]
40. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease. El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]